What are the effects of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population?
A retrospective, survey-weighted, cohort analysis study conducted by Richardson et al. (2010) found that guideline-recommended cardiac drugs were effective for reducing mortality in the elderly medicare heart failure population. The study found that the use of guideline-recommended cardiac drugs was associated with a reduction in all-cause mortality, as well as an increase in overall survival time for patients with heart failure.